Page last updated: 2024-09-03

way 100135 and Basal Ganglia Diseases

way 100135 has been researched along with Basal Ganglia Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Imaki, J; Ohno, Y; Shimizu, S; Tatara, A	1

Other Studies

1 other study(ies) available for way 100135 and Basal Ganglia Diseases

Article	Year
Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Aug-16, Volume: 34, Issue:6 Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Corpus Striatum; Haloperidol; Hydroxydopamines; Male; Microinjections; Motor Cortex; Neurons; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists; Statistics, Nonparametric	2010

Article

Year

Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders.

Progress in neuro-psychopharmacology & biological psychiatry, 2010, Aug-16, Volume: 34, Issue:6

Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Corpus Striatum; Haloperidol; Hydroxydopamines; Male; Microinjections; Motor Cortex; Neurons; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists; Statistics, Nonparametric

2010